MO 49.69 Altria Group $MO Hit a 52 week high of 49.96

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
MO 49.69 Altria Group $MO Hit a 52 week high of 49.96 Currently at 49.69 -0.18 -0.36% With a day low of 49.60 and a total volume of 500,241.

MO Altria Group Recent Headline News

Fitch Rates Altria's Proposed $1B Debt Issuance 'BBB+'
Business Wire - 1 hr 53 mins ago
Fitch Ratings has assigned a 'BBB+' rating to Altria Group, Inc.'s (Altria) proposed senior unsecured notes issuance. A total of $1 billion in notes are being issued with a maturity date in 2020. The Rating Outlook is Stable. At Sept. 30, 2014, Altria had approximately $14 billion of total debt.
MO: 49.36 (-0.51)

Altria Group (MO) Breaks Through Support at $49.62
Comtex SmarTrend(R) - 2 hrs 59 mins ago
Shares of Altria Group (NYSE:MO) opened today below their pivot of $49.85 and have already reached the first level of support at $49.62. Investors may be interested in a cross of the next downside pivot targets of $49.37 and $48.88.
MO: 49.36 (-0.51)

The Dow 30: Are We Up For Bubble Trouble?
Timberwolf Equity Research - at Seeking Alpha - Tue Nov 11, 7:53AM CST

MMM: 156.93 (-0.73), GE: 26.27 (-0.20), NKE: 94.77 (-0.19), HON: 96.81 (-0.46), UNH: 95.28 (+0.53), C: 53.96 (+0.07), KRFT: 57.66 (-0.25), INTC: 33.24 (-0.02), T: 35.05 (-0.07), V: 249.15 (-1.06), DIA: 175.80 (-0.15), MSFT: 48.78 (-0.11), CSCO: 25.16 (+0.01), TRV: 103.10 (+0.11), KO: 42.51 (+0.12), HD: 98.13 (-0.03), DIS: 89.53 (-0.25), BAC: 17.37 (unch), MO: 49.36 (-0.51), HPQ: 36.73 (-0.17), AA: 16.40 (+0.08), GS: 191.63 (-0.17), MCD: 95.03 (-0.08), GM: 31.21 (+0.09), AIG: 54.43 (+0.07), PG: 89.62 (+0.17), CVX: 118.41 (+0.49), VZ: 50.48 (-0.24)

Altria vs. Reynolds American: Which Is the Better Cigarette Stock?
Leo Sun, The Motley Fool - Motley Fool - Tue Nov 11, 7:30AM CST
The two biggest players in the U.S. cigarette market, Altria and Reynolds American , are clashing over a steadily shrinking market. Altria controls around half of that market, while Reynolds will control roughly 34% after its $27.4 billion...
RAI: 65.14 (-0.33), LO: 61.98 (-0.16), MO: 49.36 (-0.51)

'Mad Money' Lightning Round: Intel Is Underrated by Wall Street
at The Street - Tue Nov 11, 5:00AM CST
Cramer doesn't think now is a good time for Caterpillar.
KMI: 38.51 (+0.01), GD: 141.22 (+0.40), LMT: 186.96 (-0.03), RTN: 103.44 (-0.08), DDD: 34.72 (-1.50), NOC: 136.65 (+1.00), MO: 49.36 (-0.51), INTC: 33.24 (-0.02), KERX: 15.94 (-0.49), WPRT: 6.09 (+0.21), IBM: 162.95 (-0.54), MRK: 59.50 (+0.69), GM: 31.21 (+0.09), PG: 89.62 (+0.17), CAT: 102.18 (-0.03)

Cramer's Lightning Round - I Curse The Day I Bought General Motors (11/10/14)
SA Editor Miriam Metzinger - at Seeking Alpha - Tue Nov 11, 3:18AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Monday November 10. Bullish Calls: Merck (NYSE: MRK ): Cramer prefers Merck to Procter & Gamble. Intel (NASDAQ: INTC ): "INTC is underrated...
GD: 141.22 (+0.40), LMT: 186.96 (-0.03), NOC: 136.65 (+1.00), DDD: 34.72 (-1.50), MO: 49.36 (-0.51), INTC: 33.24 (-0.02), HPQ: 36.73 (-0.17), KERX: 15.94 (-0.49), WPRT: 6.09 (+0.21), IBM: 162.95 (-0.54), MRK: 59.51 (+0.70), SSYS: 101.58 (-3.31), GM: 31.21 (+0.09), CAT: 102.18 (-0.03), LINE: 23.38 (-0.34), PG: 89.62 (+0.17)

There Can Only Be One Winner In Big Tobacco's E-Cig War
Rupert Hargreaves - Seeking Alpha - Tue Nov 11, 3:04AM CST
This time last year everyone was raving about the electronic cigarette, or e-cig business, touting it as the next big thing in the tobacco world. As an early mover, Lorillard (NYSE: LO ), with its blu brand, quickly captured a large share of the...
RAI: 65.14 (-0.33), LO: 61.98 (-0.16), MO: 49.36 (-0.51)

Earnings Look Back: Altria Group Is Up 5.0% Since Reporting Quarterly Results 1 Week Ago (MO)
Comtex SmarTrend(R) - Mon Nov 10, 8:05AM CST
When Altria Group (NYSE:MO) reported earnings 11 days ago on October 30th, 2014, analysts, on average, expected the company to report earnings of $0.68 on sales of $4.7 billion. Altria Group actually reported earnings of $0.69 per share on sales of $4.8 billion, beating EPS estimates by $0.01 and beating revenue estimates by $10.7 million. Since the company's report, shares of Altria Group have risen from $47.50 to $49.86, representing a gain of 5.0% in the past 11 days.
MO: 49.36 (-0.51)


Massachusetts town weighs nation's 1st tobacco ban
By AMY CRAWFORD - AP - Sun Nov 09, 9:24AM CST
WESTMINSTER, Mass. (AP) — The cartons of Marlboros, cans of Skoal and packs of Swisher Sweets are hard to miss stacked near the entrance of Vincent's Country Store, but maybe not for much longer: All tobacco products could become contraband if local health officials get their way.
MO: 49.36 (-0.51)

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
at The Street - Fri Nov 07, 7:19PM CST
Next week Cramer will be watching earnings from WhiteWave Foods, DR Horton and Wal-Mart, among many others.
DHI: 23.88 (+0.45), KMI: 38.51 (+0.01), HK: 2.95 (-0.30), KSS: 56.01 (-0.56), GE: 26.27 (-0.20), LMT: 186.96 (-0.03), AVAV: 29.38 (+0.08), WMT: 79.02 (-0.42), SNE: 20.61 (+0.11), M: 58.69 (-0.57), SDRL: 21.40 (-0.36), T: 35.05 (-0.07), W: 23.83 (-4.27), OPK: 8.51 (-0.12), QCOM: 69.69 (+0.33), TWTR: 39.06 (-0.53), EPR: 57.75 (+0.27), AAPL: 108.85 (+0.02), HSIC: 129.13 (-0.49), CSCO: 25.16 (+0.01), WFM: 47.17 (-0.88), CY: 10.13 (-0.03), MU: 33.03 (-0.06), SWKS: 60.68 (-0.29), IRM: 37.72 (+0.08), BAC: 17.37 (unch), MO: 49.36 (-0.51), CSX: 36.55 (-0.01), WWAV: 36.15 (+0.15), GILD: 108.05 (+1.03), TXN: 51.26 (-0.30), BPL: 77.24 (-1.38), JCP: 7.11 (-0.11), JWN: 70.90 (-1.49), BABA: 115.55 (-3.60)

Earnings Analysis - Altria Group
CapitalCube - Seeking Alpha - Fri Nov 07, 1:20PM CST
By CapitalCube Altria Group, Inc. (NYSE: MO ) reported preliminary financial results for the quarter ended September 30, 2014. Altria Group, Inc. just reported its preliminary financial results based on which we provide a unique corporate earnings...
MO: 49.36 (-0.51)

3 Buy-Rated Dividend Stocks Taking The Lead: PAA, MO, NS
at The Street - Fri Nov 07, 9:30AM CST
These 3 dividend stocks are rated a Buy by TheStreet
NS: 60.05 (-0.09), MO: 49.36 (-0.51), PAA: 52.56 (-0.11)

Altria Group: 5 Keys to Management's Growth Strategy
Dan Caplinger, The Motley Fool - Motley Fool - Fri Nov 07, 7:30AM CST
Altria headquarters. Source: Altria. In the tobacco industry, Altria Group has provided leadership for decades, rewarding those long-term shareholders who've stayed the course with the company throughout its long history. Altria continued its...
RAI: 65.14 (-0.33), PM: 88.00 (-0.42), LO: 61.98 (-0.16), MO: 49.36 (-0.51)

It's Time to Buy Philip Morris Stock. Here's Why.
Rich Smith, The Motley Fool - Motley Fool - Thu Nov 06, 2:00PM CST
The commonly accepted wisdom in the cigarette industry goes something like this: Smoking is in decline in the U.S. Therefore, if you want to make money on tobacco, you must look abroad. You must buy Philip Morris International stock. And as it...
PM: 88.00 (-0.42), LO: 61.98 (-0.16), MO: 49.36 (-0.51)

Dividend Growth Strategy: Take The Beaten Path Or Road Less Traveled?
Adam Aloisi - at Seeking Alpha - Thu Nov 06, 1:52PM CST

KO: 42.51 (+0.12), BDX: 128.34 (+0.04), HD: 98.13 (-0.03), AMT: 99.00 (-0.30), AMGN: 162.75 (-0.34), O: 46.81 (-0.29), MO: 49.36 (-0.51), CSX: 36.55 (-0.01), LUV: 39.53 (+0.41), T: 35.05 (-0.07), JNJ: 108.85 (+0.03), RCL: 67.41 (-0.57), V: 249.15 (-1.06), QCOM: 69.69 (+0.33), MCD: 95.03 (-0.08), PG: 89.62 (+0.17), MSFT: 48.78 (-0.11), CVX: 118.41 (+0.49), AAPL: 108.85 (+0.02), WAG: 67.28 (-0.50)

Is Altria Group Inc. a Good Sin Stock to Buy?
Selena Maranjian, The Motley Fool - Motley Fool - Thu Nov 06, 11:03AM CST
Source: Wikimedia Commons. You know about socially responsible investing, or SRI , in which investors steer clear on principle of certain industries -- for example, guns, alcohol, tobacco, gambling, military equipment, and prisons -- objecting to...
MO: 49.36 (-0.51)

5 Top Dividend Stocks for Retirees to Buy
Bob Ciura, The Motley Fool - Motley Fool - Thu Nov 06, 10:55AM CST
Investors in or nearing retirement who are looking for additional income might consider buying stocks that pay dividends . Dividend-paying stocks can offer significant income potential, which is often important for retirees, particularly as interest...
WMT: 79.02 (-0.42), MCD: 95.03 (-0.08), PG: 89.62 (+0.17), MO: 49.36 (-0.51), PEP: 96.93 (-0.04)

Will Altria's Dividend Go Up In Smoke, Or Be Taken To Even Higher Levels On A Cloud Of Vapor?
Regarded Solutions - at Seeking Alpha - Thu Nov 06, 10:41AM CST

PM: 88.00 (-0.42), MO: 49.36 (-0.51), VPCO: 1.60 (-0.15)

Dividend Income Update - October 2014
Dividend Mantra - Seeking Alpha - Wed Nov 05, 6:22PM CST
Another month has passed by, and it's time for me to post an article on my favorite subject: dividend income. The reason why I love to post articles on dividend income is because it's pure numbers. It's hard to argue the success of long-term dividend...
KO: 42.51 (+0.12), GE: 26.27 (-0.20), MDT: 68.72 (+0.01), RTN: 103.44 (-0.08), SYY: 38.51 (-0.14), MO: 49.36 (-0.51), BNS: 60.48 (+0.58), ITW: 92.72 (-0.35), PM: 88.00 (-0.42), BAX: 70.68 (+0.05), ARCP: 8.56 (+0.06)

Altria Group Shares Up 17.2% Since SmarTrend's Buy Recommendation (MO)
Comtex SmarTrend(R) - Wed Nov 05, 5:05PM CST
SmarTrend identified an Uptrend for Altria Group (NYSE:MO) on August 18th, 2014 at $42.45. In approximately 3 months, Altria Group has returned 17.18% as of today's recent price of $49.74.
MO: 49.36 (-0.51)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 266

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 208

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 33

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 0

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 164

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 284

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 171

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 208

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Precious Metals and Energy Investors' Strategies

Updated Category News Views 143

Current Trends in Precious Metals The appeal of precious metals like gold and silver continues to gather momentum, particularly in light of recent global events. Many analysts believe that geopolitical tensions have created a catalyst for increased interest in gold as a safe haven. As governments grapple with economic challenges, investors are keenly observing changes in...

Continue Reading
Understanding P/E Ratios in the Context of Casey's General Stores

Updated Category News Views 175

Analyzing P/E Ratios for Investment Decisions In today’s market, understanding the performance metrics of stocks is vital. Currently, Casey's General Stores Inc. (NASDAQ: CASY) is noted at an impressive share price of $536.66. This reflects a modest increase of 0.33%. In examining market trends, the past month saw a slight decline of 4.39% in share value. However,...

Continue Reading
China's New Lending Outlook: Economic Recovery Strategies

Updated Category News Views 135

China's Recent New Lending Trends Recent updates reveal a significant rise in new bank lending in China. However, it didn't quite meet expectations, as analysts had hoped for a stronger performance. After disappointing figures in July, which hit a 15-year low, new data shows that Chinese banks issued around 900 billion yuan (approximately $126.86 billion) in new loans in...

Continue Reading
ParkOhio Shares Important Quarterly Dividend News for Investors

Updated Category News Views 177

ParkOhio Holdings Announces Latest Dividend Declaration Park-Ohio Holdings Corp. (NASDAQ: PKOH) recently declared a significant quarterly cash dividend of $0.125 per share to its common stockholders. This distribution demonstrates the company's ongoing commitment to providing returns to its shareholders. This dividend will be payable soon, marking another positive...

Continue Reading
Investigation Launched for Tourmaline Bio's Shareholders

Updated Category News Views 259

Investigation Overview on Tourmaline Bio, Inc. Recently, Monteverde & Associates PC, a renowned law firm, has initiated an investigation concerning Tourmaline Bio, Inc. (NASDAQ: TRML) and its proposed sale to Novartis AG. This potential acquisition raises several questions about the fairness of the deal, specifically regarding the cash payment offered to shareholders....

Continue Reading